Mirae Asset Global Investments Co., Ltd. Cytokinetics Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Cytokinetics Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,933 shares of CYTK stock, worth $181,547. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,933
Previous 4,256
7.59%
Holding current value
$181,547
Previous $224,000
17.41%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CYTK
# of Institutions
404Shares Held
126MCall Options Held
3.24MPut Options Held
2.14M-
Black Rock Inc. New York, NY14.7MShares$677 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$550 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$496 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$364 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$285 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.35B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...